Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript
Yahoo FinanceMay 3 13:02 ET
RBC Capital Gives a Buy Rating to Aurinia Pharmaceuticals (AUPH)
TipRanksMay 3 06:41 ET
Aurinia Pharmaceuticals' LUPKYNIS: A Strong Buy on Surging Sales and Positive Market Indicators
TipRanksMay 3 06:36 ET
Earnings Call Summary | Aurinia Pharmaceuticals(AUPH.US) Q1 2024 Earnings Conference
The following is a summary of the Aurinia Pharmaceuticals Inc. (AUPH) Q1 2024 Earnings Call Transcript:Financial Performance:Aurinia reported Q1 net revenue of $50.3 million, marking a 46% YoY growth.
moomoo AIMay 2 14:48 ET · Conference Call
Aurinia Pharmaceuticals Sees Robust Growth in 2024
TipRanksMay 2 06:38 ET
Earnings Flash (AUPH) AURINIA PHARMACEUTICALS Posts Q1 Revenue $50.3M, Vs. Street Est of $47.1M
06:12 AM EDT, 05/02/2024 (MT Newswires) -- Earnings Flash (AUPH) AURINIA PHARMACEUTICALS Posts Q1 Revenue $50.3M, vs. Street Est of $47.1M
MT NewswiresMay 2 06:12 ET
Express News | Aurinia Pharmaceuticals Inc: Sees Cash Flow Positive, Excluding Share Repurchases, in Q2 2024, With Estimated Cost Savings of $50 to $55 Mln Annually
ReutersMay 2 06:04 ET
Express News | Aurinia Pharmaceuticals Inc: Reiterates 2024 Net Product Revenue Guidance of $200 to $220 Mln
ReutersMay 2 06:04 ET
Express News | Aurinia Reiterates 2024 Net Product Revenue Guidance Of $200M-$220M
BenzingaMay 2 06:03 ET
Express News | Aurinia Pharmaceuticals Q1 Operating Income USD -13.253 Million
ReutersMay 2 06:00 ET
Express News | Aurinia Pharmaceuticals Q1 Net Income USD -10.749 Million
ReutersMay 2 06:00 ET
Express News | Aurinia Pharmaceuticals Q1 Product Revenue USD 48.073 Million
ReutersMay 2 06:00 ET
Express News | Aurinia Pharmaceuticals Q1 Pretax Profit USD -10.01 Million
ReutersMay 2 06:00 ET
Express News | Aurinia Pharmaceuticals Q1 EPS USD -0.07
ReutersMay 2 06:00 ET
Press Release: Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results -- Achieved $50.3 million in total net revenue and $48.1 million in net product revenue for the first qu
Dow JonesMay 2 06:00 ET
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results May 2, 2024 • 6:00 am EDT Download as PDF Related Documents E
Aurinia PharmaceuticalsMay 2 06:00 ET
Analysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO), Aurinia Pharmaceuticals (AUPH) and 908 Devices (MASS)
TipRanksMay 2 02:22 ET
Leerink Partners Keeps Their Buy Rating on Aurinia Pharmaceuticals (AUPH)
TipRanksMay 2 02:20 ET
Express News | Aurinia Pharmaceuticals Announced Several Initiatives To Improve Understanding Of The Seriousness Of Lupus Nephritis And The Need For Frequent Screening And Appropriate Management
BenzingaMay 1 06:19 ET
Express News | Aurinia Underscores Enduring Commitment to People Living With Lupus Nephritis Through Innovative Advocacy and Education Initiatives for Lupus Awareness Month
ReutersMay 1 06:00 ET
No Data
No Data